EUDA Health (EUDA) Projected to Post Quarterly Earnings on Tuesday

EUDA Health (NASDAQ:EUDA) will likely be announcing its results before the market opens on Tuesday, July 28th. Analysts expect EUDA Health to announce earnings of $0.40 per share and revenue of $9.6090 million for the quarter.

EUDA Health (NASDAQ:EUDA) last posted its quarterly earnings results on Tuesday, May 5th. The company reported ($0.44) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.20) by $0.76. The business had revenue of $1.92 million during the quarter, compared to the consensus estimate of $3.90 million.

EUDA Health Stock Performance

Shares of EUDA stock opened at $14.48 on Tuesday. The firm’s 50 day moving average is $15.01 and its 200 day moving average is $17.77. EUDA Health has a 12 month low of $5.26 and a 12 month high of $86.00.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on EUDA. Zacks Research upgraded shares of EUDA Health from a “strong sell” rating to a “hold” rating in a research note on Friday, May 8th. Weiss Ratings downgraded EUDA Health from a “sell (d)” rating to a “sell (e+)” rating in a research report on Friday, May 8th. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $55.00.

Institutional Investors Weigh In On EUDA Health

A hedge fund recently raised its stake in EUDA Health stock. Citadel Advisors LLC boosted its position in shares of EUDA Health Holdings Limited (NASDAQ:EUDA) by 57.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 44,631 shares of the company’s stock after acquiring an additional 16,321 shares during the period. Citadel Advisors LLC owned 0.12% of EUDA Health worth $78,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 4.35% of the company’s stock.

About EUDA Health

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.